Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 10, 2025 • 8:31 PM ET

Date/Time Source News Release
08/09/2022 07:00 AM EDT Business Wire Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update
07/26/2022 04:42 PM EDT PR Newswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION
07/16/2022 12:35 AM EDT PR Newswire Shareholder Alert - The M&A Class Action Firm Continues Investigating the Merger - FSTX, EPZM, STCN, SIMO, VMW, VHAQ
07/09/2022 07:12 PM EDT GlobeNewswire Lifshitz Law PLLC Announces Investigation of MANT, LBSI, USAK and EPZM
07/06/2022 05:16 PM EDT PR Newswire Moore Kuehn Encourages EPZM, RDUS, OBCI, and CNVY Investors to Contact Law Firm
07/05/2022 02:44 PM EDT GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Epizyme, Inc. (Nasdaq - EPZM), USA Truck, Inc. (Nasdaq - USAK), Zendesk, Inc. (NYSE - ZEN), F-star Therapeutics, Inc. (Nasdaq - FSTX)
06/27/2022 08:56 AM EDT Business Wire EPZM Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Epizyme, Inc. Is Fair to Shareholders
06/27/2022 01:01 AM EDT Business Wire Ipsen to acquire Epizyme, expanding its portfolio in oncology
06/02/2022 07:00 AM EDT Business Wire Epizyme Presents Updates from SYMPHONY-1 Tazemetostat + R2 Combination Study in Relapsed/Refractory Follicular Lymphoma at the 2022 ASCO Annual Meeting
05/17/2022 07:00 AM EDT Business Wire Epizyme To Participate in H.C. Wainwright Global Investment Conference
Page

Additional News

As of June 10, 2025 • 8:31 PM ET

Date/Time Source News Release
08/12/2022 11:39 AM EDT Zacks Aptinyx's (APTX) Mid-Stage Fibromyalgia Study Fails to Meet Goal
08/10/2022 03:16 PM EDT Zacks Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
08/09/2022 08:29 AM EDT SeekingAlpha Epizyme GAAP EPS of -$0.21, revenue of $27.5M
08/09/2022 08:25 AM EDT Zacks Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates
07/15/2022 12:00 AM EDT Channelchek Biotech Stocks Outperformance Factors - Will they Continue?
07/05/2022 04:13 PM EDT SeekingAlpha Epizyme Acquisition By Ipsen: CVR Value
06/29/2022 11:51 AM EDT Zacks Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
06/27/2022 12:24 PM EDT Motley Fool Why Epizyme Stock Is Soaring Today
06/27/2022 11:00 AM EDT Zacks Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
06/27/2022 10:20 AM EDT InvestorPlace Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.